Fenugreek Supplement Bottles Recalled for Pen Fragment Contamination
Vitality Works is recalling 1,025 bottles of fenugreek capsules due to contamination with pen pieces. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with confirmed foreign material contamination (pen pieces) posing a potential choking hazard. No illnesses or injuries have been reported; the risk is identified but harm has not yet occurred.
Plain-English summary
Vitality Works, Inc. is recalling approximately 1,025 bottles of 100 Vegetarian Fenugreek Capsules (90 count, 600mg) due to contamination with foreign material. The recalled product is Lot 2023-06871 with an expiration date of 07/2028, packaged in 150cc amber glass bottles with white polypropylene caps.
The capsules have been found to contain pieces of a pen (writing utensil). Ingestion of these fragments could pose a choking or injury hazard to consumers.
The affected bottles were distributed to 55 retail customers representing 284 individual stores located within the United States. All distribution occurred within the US with no foreign sales or distribution to US Government agencies. The recall notification was sent to distributors on August 24, 2023.
Consumers who have purchased this product should stop taking it and return the bottle to their place of purchase for a refund.
The recalled product
- Product
- 100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
- Manufacturer
- Vitality Works, Inc
- Category
- Drug — Dietary Supplement
- Hazard
- foreign-material
- choking
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27